Cargando…
Low expression of KCNN3 may affect drug resistance in ovarian cancer
Drug resistance is a principal contributor to the poor prognosis of ovarian cancer (OC). Therefore, identifying factors that affect drug resistance in OC is critical. In the present study, 51 OC specimens from lab collections were immunohistochemically tested, public data for 489 samples from The Ca...
Autores principales: | Liu, Xia, Wei, Luwei, Zhao, Bingbing, Cai, Xiangxue, Dong, Caihua, Yin, Fuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072180/ https://www.ncbi.nlm.nih.gov/pubmed/29901154 http://dx.doi.org/10.3892/mmr.2018.9107 |
Ejemplares similares
-
KCNN2 polymorphisms and cardiac tachyarrhythmias
por: Yu, Chih-Chieh, et al.
Publicado: (2016) -
Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA
por: Ke, Yao, et al.
Publicado: (2021) -
Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma
por: Fuest, Sebastian, et al.
Publicado: (2022) -
KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer
por: Zhao, Haiyue, et al.
Publicado: (2016) -
Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation
por: Ellinor, Patrick T., et al.
Publicado: (2010)